High-energy DHA/ARA-enriched human milk in the first 2 weeks to lower lung problems in extremely preterm babies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this phase II, parallel-group, masked randomized trial, extremely preterm infants fed human milk are assigned to receive either a DHA/ARA-enriched, fortified diet or a standard fortified human milk diet during the first 14 days of life. The study aims to determine effects on respiratory morbidity and lung function. Participants are enrolled if they are ≤28 weeks gestational age and within 72 hours after birth, excluding those with congenital abnormalities or terminal conditions. The lead sponsor is the University of Alabama at Birmingham, with NHLBI collaboration, and the study is conducted at UAB in Birmingham, AL.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Gestational age ≤ 28 weeks of gestation
* Postnatal age \< 72 hours

Exclusion Criteria:

* Congenital malformations
* Chromosomal anomalies
* Terminal illness needing to limit or withhold support

Where it's running

• University of Alabama at Birmingham
  Birmingham, Alabama, United States Recruiting

Study contacts

• Principal investigator: Ariel A. Salas, MD, MSPH — University of Alabama at Birmingham
• Study coordinator: Ariel A. Salas, MD, MSPH
• Email: asalas@uabmc.edu
• Phone: 205-934-4680

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adjusting ventilator PEEP to improve lung compliance and heart function in preterm infants

  We will try changing the ventilator's PEEP settings in babies born before 34 weeks who need breathing support to see if the PEEP that gives the best lung compliance improves heart output and oxygen levels.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT06512935

• Lung Ultrasound Score to predict BPD in very preterm babies

  This study tests whether lung ultrasound scores in the first two weeks of life can predict which extremely preterm babies will develop bronchopulmonary dysplasia.

  Recruiting at 4 sites Azienda USL Reggio Emilia - IRCCS · Modena and 3 other locations · NCT07633184

• Using enteral (tube) feeding as recommended for adults with cancer.

  This project will see how well enteral (tube) feeding recommendations are followed by adults hospitalized for cancer who need enteral nutrition.

  Recruiting Institut Curie · Paris · NCT07571564

• Caffeine in pregnancy: how the mother and baby handle it during delivery

  This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.

  Recruiting Phase 1 Indiana University · Indianapolis, Indiana · NCT07570121

• IVIG for bronchopulmonary dysplasia in infants born at 28 weeks or earlier

  This trial will try intravenous immunoglobulin (IVIG) given over five days to see if it helps very preterm infants (≤28 weeks) who show early signs of bronchopulmonary dysplasia.

  Recruiting Phase 2 International Peace Maternity and Child Health Hospital · Shanghai · NCT07561125

• Stepwise enteral feeding plan to improve nutrition for critically ill children in the PICU.

  This will try a step-by-step tube-feeding plan to see if it helps critically ill infants and children in the pediatric ICU get the nutrition they need.

  Recruiting Ain Shams University · Cairo, Abbasia · NCT07307027

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.